UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 66 filers reported holding UROGEN PHARMA LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,053,272 | +33.7% | 75,180 | -1.2% | 0.07% | +48.9% |
| Q2 2023 | $787,500 | +16.4% | 76,087 | +3.9% | 0.04% | +18.4% |
| Q1 2023 | $676,414 | +4.6% | 73,205 | +0.4% | 0.04% | +2.7% |
| Q4 2022 | $646,898 | +4.5% | 72,931 | -2.0% | 0.04% | +2.8% |
| Q3 2022 | $619,000 | -31.6% | 74,431 | -32.6% | 0.04% | -18.2% |
| Q2 2022 | $905,000 | -3.8% | 110,457 | +2.3% | 0.04% | +18.9% |
| Q1 2022 | $941,000 | -2.4% | 107,990 | +6.5% | 0.04% | +8.8% |
| Q4 2021 | $964,000 | -61.6% | 101,359 | -32.1% | 0.03% | -63.4% |
| Q3 2021 | $2,511,000 | -32.0% | 149,260 | -38.2% | 0.09% | -29.0% |
| Q2 2021 | $3,690,000 | -34.0% | 241,637 | -15.7% | 0.13% | -28.0% |
| Q1 2021 | $5,587,000 | +203.8% | 286,805 | +181.0% | 0.18% | +180.0% |
| Q4 2020 | $1,839,000 | – | 102,053 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |